What is Thymosin Alpha-1 studied for?

Published and ongoing research looks at chronic hepatitis B and C as adjunct therapy; immune response in sepsis and critical illness; t-cell function in immunosuppressed populations. These are areas of study, not promised outcomes.

Is Thymosin Alpha-1 FDA-approved?

Thymosin Alpha-1 has not been evaluated by the FDA. Elevate Chicago lists it for education and research reference only — it is not prescribed as medical care and is not intended for human consumption.

How is Thymosin Alpha-1 typically used?

Used clinically in courses under supervision where approved Discussed in research contexts around recurrent infection and immune resilience Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.

What are the risks and unknowns with Thymosin Alpha-1?

Not FDA-approved; research use only in the United States Immune modulation warrants caution with autoimmune conditions Was removed from the FDA's bulk compounding list, which is why pharmacy access changed

Longevity & immune

Thymosin Alpha-1

Written by the Elevate Clinical Team

Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on August 19, 2026. Independent clinical review pending.

Also known as Tα1, Zadaxin

A thymic peptide used clinically in some countries as an immune modulator; not approved in the United States.

What it is

Thymosin alpha-1 is a naturally occurring thymic peptide that helps mature T cells and modulate immune response. It is approved in more than 30 countries for hepatitis B and C and as a vaccine adjuvant, and it was studied during COVID-19. It is not FDA-approved.

What it's studied for

Chronic hepatitis B and C as adjunct therapy
Immune response in sepsis and critical illness
T-cell function in immunosuppressed populations

How it's used in practice

Used clinically in courses under supervision where approved
Discussed in research contexts around recurrent infection and immune resilience

What you should know before asking about it

Not FDA-approved; research use only in the United States
Immune modulation warrants caution with autoimmune conditions
Was removed from the FDA's bulk compounding list, which is why pharmacy access changed

Frequently asked questions.

What is Thymosin Alpha-1?: Thymosin alpha-1 is a naturally occurring thymic peptide that helps mature T cells and modulate immune response. It is approved in more than 30 countries for hepatitis B and C and as a vaccine adjuvant, and it was studied during COVID-19. It is not FDA-approved.
What is Thymosin Alpha-1 studied for?: Published and ongoing research looks at chronic hepatitis B and C as adjunct therapy; immune response in sepsis and critical illness; t-cell function in immunosuppressed populations. These are areas of study, not promised outcomes.
Is Thymosin Alpha-1 FDA-approved?: Thymosin Alpha-1 has not been evaluated by the FDA. Elevate Chicago lists it for education and research reference only — it is not prescribed as medical care and is not intended for human consumption.
How is Thymosin Alpha-1 typically used?: Used clinically in courses under supervision where approved Discussed in research contexts around recurrent infection and immune resilience Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.
What are the risks and unknowns with Thymosin Alpha-1?: Not FDA-approved; research use only in the United States Immune modulation warrants caution with autoimmune conditions Was removed from the FDA's bulk compounding list, which is why pharmacy access changed

Sources

1.Published literature on Thymosin Alpha-1 Tα1, Zadaxin— PubMed, U.S. National Library of Medicine
2.Compounding and the FDA: questions and answers— U.S. Food & Drug Administration
3.Bulk drug substances nominated for use in compounding under section 503A— U.S. Food & Drug Administration
4.Test directory and patient service center locator— Quest Diagnostics

About this page

Written by the Elevate Clinical Team

Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on August 19, 2026. Independent clinical review pending. Educational content only — not medical advice, not a diagnosis, and not an offer to sell any prescription product.

This page is educational reference material. It is not medical advice, not a diagnosis, and not an offer to sell any product. Prescription therapies are dispensed only through licensed, FDA-registered compounding pharmacies after a physician evaluation. Compounds identified as research use only are not FDA-approved, are not prescribed as medical care, and are not intended for human or animal consumption. Availability, formulations and regulatory status change over time.

Begin your intake Peptide therapy overview